A new global health analysis suggests a large number of Americans are allergic to dairy but don’t realize it. The data also shows the British have nearly twice the rate of lactose intolerancethan Americans, Australians and the French. 

The health data was compiled by the new wellness book, Beyond Body, which integrates health analytics to create a personalized wellness plan based on the reader’s health and allergies. The analytics are derived from 28 personalized questions readers answer for the book’s research.

The data involved more than 1.6 million people across the UK, US, France and Australia. It included 1.2 million Americans, 287,154 French, 84,414 Britons and 67,819 Australians.

Nutritionist and author, Christine Zalnieraite, says this data is helping people around the globe manage their allergies and lactose intolerance by giving them a personalized nutrition and fitness regimen based on their health conditions.

“This data suggests there are a lot more people suffering from lactose intolerance but they don’t realize it,” said Zalnierate. “Research suggests that roughly 36 percent of Americans have an allergy to dairy, so if only 4 percent say they experience it, this tells us that many people are suffering from lactose intolerance but aren’t doing anything to treat it.”

Lactose intolerance is a condition that prevents people from properly digesting lactose in dairy. It can lead to symptoms that include: Stomach pain, abdominal cramps, bloating, diarrhea, constipation, flatulence, nausea and vomiting.

The Beyond Body health analysis found that 8 percent of Britons say they are lactose intolerant, compared to 4 percent for Americans, Australians, and French.

“There is no one-size-fits-all guidebook to wellness, and each body works differently,” said  Zalnierate. “Our analytics are very detailed, allowing us to create meal plans around allergies, intolerances, and even food preferences, making it easier for people to follow a personalized health regimen.” 

Food Intolerances Across the US, UK, Australia and France

Roughly 25 percent of respondents in the US and Australia said they have some form of nut allergies, which is drastically more than public research suggests. Roughly 3 million Americans are believed to have nut allergies or 1.1 percent of the population. 

Zalnierate said it’s very likely people are confusing nut allergies with another allergy and not realizing it.

“It’s so important to understand how our nutrition and what we eat impacts our body,” said Zalnierate. “This is where our analytics is truly revolutionizing the wellness industry. Never before have we integrated such personal analytics into a book. When people feel better with a nutrition or health plan, they’re more likely to stick to it.”

The data also found that 12 percent of French respondents and 15 percent of Britons say they have a nut allergy.

Beyond Body creates meal plans and recipes based on the personal analytics that are discovered during each reader’s assessment. For readers who are lactose intolerant or have food allergies, it includes recipes and meal plans designed around their allergies. 

About Beyond Body

Beyond Body takes analytics from a reader's profile and creates a customized wellness plan for their overall health and desired body needs and body goals. It's the first hardcover book to integrate analytics into a customized wellness plan based on the reader's physical and mental health as well as their current conditions and health history.

An exciting new study from the team of Lucintel found that Biological data visualization market is expected to grow at a CAGR of 9%-11%. There are significant money making opportunities available in this market and companies planning to enter this market need to differentiate in order to maximize their return on investment.

Download Brochure of this report by clicking on https://www.lucintel.com/biological-data-visualization-market.aspx

The biological data visualization market is segmented based on segments, such as technique, platform, application, end use, and region. In this market, sequencing is the largest segment by technique, whereas cell and organism imaging is largest by application. Players can benefit from the available opportunities like increasing research and development activities in biotechnology sectors, rising adoption of sequencing technique, and growth in biotechnology sectors.

Thermo Fisher Scientific, QIAGEN, B&D, Agilent Technologies, 3M, Carl Zeiss, Oxford Instruments, Olympus, GE Healthcare, and Clarivate Analytics are some of the major players profiled in this 150 page report.

Request Sample Pages by clicking on https://www.lucintel.com/biological-data-visualization-market.aspx

Some of the Key Questions answered in this exclusive report are:

Q.1 What are some of the most promising, high-growth opportunities for the biological data visualization market by technique (sequencing, magnetic resonance imaging, microscopy, X-ray crystallography, and others), platform (windows, mac OS, linux, and others), application (cell & organism imaging, structural biology & molecular modeling, genomic analysis, alignments, phylogeny, & evolution, and systems biology), end use (academic research, hospitals & clinics, pharmaceutical & biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?

Q.2 Which segments will grow at a faster pace and why?

Q.3 What are the business risks and threats to the biological data visualization market?

Q.4 What are some changing demands of customers in the biological data visualization market?

Q.5 What are the new developments in the biological data visualization market? Which companies are leading these developments?

Q.6 What strategic initiatives are being implemented by key players for business growth?

Q.7 What are some of the competitive products and processes in this biological data visualization area and how big of a threat do they pose for loss of market share via product substitution?

Q.8 What M&A activity has occurred in the last 5 years in this biological data visualization market?

This unique report from Lucintel will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link This email address is being protected from spambots. You need JavaScript enabled to view it.

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Tel. 972.636.5056
Cell: 303.775.0751

An exciting new study from the team of Lucintel found that CRISPR market is expected to grow at a CAGR of 24%-26%. There are significant money making opportunities available in this market and companies planning to enter this market need to differentiate in order to maximize their return on investment.

Download Brochure of this report by clicking on https://www.lucintel.com/crispr-market.aspx

The CRISPR market is segmented based on segments, such as product, service, application, and end user, and region. In this market, biomedical is largest by application. Players can benefit from the available opportunities like increasing government and private fundings and the presence of major gene therapy and pharma companies in the region.

Cellecta, Thermo Fisher, GeneCopoeia, Applied StemCell, Synthego, OriGene Technologies, Horizon Discovery, Merck, and GenScript are some of the major players profiled in this 150 page report.

Request Sample Pages by clicking on https://www.lucintel.com/crispr-market.aspx

Some of the Key Questions answered in this exclusive report are:

Q.1 What are some of the most promising, high-growth opportunities for the CRISPR market by product (enzymes, kits, gRNA, libraries, and design tools), service (gRNA design and cell line engineering), application (biomedical, agricultural, industrial, and biological research), end user (pharma & biopharma companies, biotechnology companies, academics, and contract research organization), and region (North America, Europe, Asia Pacific, and Rest of the World)?

Q.2 Which segments will grow at a faster pace and why?

Q.3 What are the business risks and threats to the CRISPR market?

Q.4 What are some changing demands of customers in the CRISPR market?

Q.5 What are the new developments in the CRISPR market? Which companies are leading these developments?

Q.6 What strategic initiatives are being implemented by key players for business growth?

Q.7 What are some of the competitive products and processes in this CRISPR area and how big of a threat do they pose for loss of market share via product substitution?

Q.8 What M&A activity has occurred in the last 5 years in this CRISPR market?

This unique report from Lucintel will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link This email address is being protected from spambots. You need JavaScript enabled to view it.

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Tel. 972.636.5056
Cell: 303.775.0751

An exciting new study from the team of Lucintel found that life science tool market is expected to grow at a CAGR of 8%-10%. There are significant money making opportunities available in this market and companies planning to enter this market need to differentiate in order to maximize their return on investment.

Download Brochure of this report by clicking on https://www.lucintel.com/life-science-tool-market.aspx

The life science tool market is segmented based on segments, such as product, technology, end use, and region. In this market, separation technologies are the largest segment by product, whereas healthcare is largest by end use. Players can benefit from the available opportunities like increasing research and development activities and rising genomic procedures for academic and clinical use.

Agilent Technologies, B&D, Roche, Bio-Rad Laboratories, Bruker, Danaher, GE Healthcare, Hitachi, Illumina, and Merck are some of the major players profiled in this 150 page report.

Request Sample Pages by clicking on https://www.lucintel.com/life-science-tool-market.aspx

Some of the Key Questions answered in this exclusive report are:

Q.1 What are some of the most promising, high-growth opportunities for the Life science tool market by product (sanger sequencing, NGS, nucleic acid preparation, PCR & qPCR, nucleic acid microarray, flow cytometry, separation technologies, mass spectrometry, electron microscopy, NMR, and others), technology (cell biology, proteomics, genomics, other analytical & sample preparation technology, and lab supplies & technologies), end use (government & academic, biopharmaceutical company, health care, industry, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?

Q.2 Which segments will grow at a faster pace and why?

Q.3 What are the business risks and threats to the life science tool market?

Q.4 What are some changing demands of customers in the life science tool market?

Q.5 What are the new developments in the life science tool market? Which companies are leading these developments?

Q.6 What strategic initiatives are being implemented by key players for business growth?

Q.7 What are some of the competitive products and processes in this life science tool area and how big of a threat do they pose for loss of market share via product substitution?

Q.8 What M&A activity has occurred in the last 5 years in this life science tool market?

This unique report from Lucintel will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link This email address is being protected from spambots. You need JavaScript enabled to view it.

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Tel. 972.636.5056
Cell: 303.775.0751